Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma

  • Federico Fallanca
  • Pierpaolo Alongi
  • Elena Incerti
  • Luigi Gianolli
  • Maria Picchio
  • Irfan Kayani
  • Jamshed B. Bomanji
Reply
First Online:

Keywords

Hodgkin Lymphoma International Prognostic Score Follicular Lymphoma International Prognostic Index Metser Clinical Risk Stratification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Fallanca F, Alongi P, Incerti E, Gianolli L, Picchio M, Kayani I, et al. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC). Eur J Nucl Med Mol Imaging. 2016;43:1837–48.Google Scholar
  2. 2.
    Adams HJ, Kwee TC. Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Br J Haematol. 2016. doi: 10.1111/bjh.14052.
  3. 3.
    Adams HJ, Nievelstein RA, Kwee TC. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol. 2015;170:185–191.CrossRefPubMedGoogle Scholar
  4. 4.
    Metser U, Mohan R, Beckley V, Moshonov H, Hodgson D, Murphy G. FDG PET/CT response assessment criteria for patients with Hodgkin’s and non-Hodgkin’s lymphoma at end of therapy: a multiparametric approach. Nucl Med Mol Imaging. 2016;50:46–53.CrossRefPubMedGoogle Scholar
  5. 5.
    Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837–842.Google Scholar
  6. 6.
    Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med. 1998;339:1506–1514.CrossRefPubMedGoogle Scholar
  7. 7.
    Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular Lymphoma International Prognostic Index. Blood. 2004;104:1258–1265. Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Federico Fallanca
    • 1
  • Pierpaolo Alongi
    • 1
    • 2
  • Elena Incerti
    • 1
  • Luigi Gianolli
    • 1
  • Maria Picchio
    • 1
  • Irfan Kayani
    • 3
  • Jamshed B. Bomanji
    • 3
    • 4
  1. 1.Unit of Nuclear MedicineIRCCS San Raffaele Scientific InstituteMilanItaly
  2. 2.Nuclear Medicine Unit, Department of Radiological SciencesSan Raffaele G. Giglio InstituteCefalùItaly
  3. 3.University College London HospitalLondonUK
  4. 4.Department of Nuclear MedicineUniversity College Hospitals NHS Foundation TrustLondonUK

Personalised recommendations